{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:34:38Z","timestamp":1770222878984,"version":"3.49.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.phrs.2019.104578","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T05:59:01Z","timestamp":1575266341000},"page":"104578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Activity-based protein profiling of the human failing ischemic heart reveals alterations in hydrolase activities involving the endocannabinoid system"],"prefix":"10.1016","volume":"151","author":[{"given":"Annelot C.M.","family":"van Esbroeck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoltan V.","family":"Varga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Di","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva J.","family":"van Rooden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikt\u00f3ria E.","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zs\u00f3fia","family":"On\u00f3di","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariusz","family":"Ku\u015bmierczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Przemyslaw","family":"Leszek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e9ter","family":"Ferdinandy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Hankemeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"van der Stelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e1l","family":"Pacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2019.104578_bib0005","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ijcard.2012.10.046","article-title":"Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations","volume":"168","author":"Finegold","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.phrs.2019.104578_bib0010","series-title":"Endocannabinoids","first-page":"393","article-title":"Endocannabinoids and the cardiovascular system in health and disease","author":"O\u2019Sullivan","year":"2015"},{"key":"10.1016\/j.phrs.2019.104578_bib0015","series-title":"Cardiovascular Effects of Marijuana and Synthetic Cannabinoids: The Good, the Bad, and the Ugly","author":"Pacher","year":"2018"},{"key":"10.1016\/j.phrs.2019.104578_bib0020","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/HYPERTENSIONAHA.105.063651","article-title":"Modulation of the endocannabinoid system in cardiovascular disease","volume":"52","author":"Pacher","year":"2008","journal-title":"Hypertension."},{"key":"10.1016\/j.phrs.2019.104578_bib0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nn.2720","article-title":"Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight","volume":"14","author":"Di Marzo","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2019.104578_bib0030","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1083\/jcb.200305129","article-title":"Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain","volume":"163","author":"Bisogno","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.phrs.2019.104578_bib0035","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0009-3084(02)00150-0","article-title":"A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation","author":"Dinh","year":"2002","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.phrs.2019.104578_bib0040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1748-1716.2011.02280.x","article-title":"The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors","volume":"204","author":"Savinainen","year":"2012","journal-title":"Acta Physiol."},{"key":"10.1016\/j.phrs.2019.104578_bib0045","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/nn.2601","article-title":"The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors","volume":"13","author":"Marrs","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2019.104578_bib0050","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.chembiol.2007.11.006","article-title":"A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol","volume":"14","author":"Blankman","year":"2007","journal-title":"Chem. Biol."},{"key":"10.1016\/j.phrs.2019.104578_bib0055","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/febs.12152","article-title":"Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways","volume":"280","author":"Ueda","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.phrs.2019.104578_bib0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2019.104578_bib0065","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev.biochem.74.082803.133450","article-title":"Structure and function of fatty acid amide hydrolase","volume":"74","author":"Mckinney","year":"2005","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.phrs.2019.104578_bib0070","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/35102582","article-title":"An anorexic lipid mediator regulated by feeding","volume":"414","author":"Rodr\u00edguez De Fonseca","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2019.104578_bib0075","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1096\/fj.03-1080fje","article-title":"Stearoylethanolamide exerts anorexic effects in mice via downregulation of liver stearoyl-coenzyme A desaturase-1 mRNA expression","volume":"18","author":"Terrazzino","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2019.104578_bib0080","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/28393","article-title":"Control of pain initiation by endogenous cannabinoids","volume":"394","author":"Calignano","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2019.104578_bib0085","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0304-3959(98)00041-4","article-title":"The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain","volume":"76","author":"Jaggar","year":"1998","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2019.104578_bib0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-psych-113011-143739","article-title":"The endocannabinoid system and the brain","volume":"64","author":"Mechoulam","year":"2012","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.phrs.2019.104578_bib0095","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd1495","article-title":"The endocannabinoid system and its therapeutic exploitation","volume":"3","author":"Di Marzo","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2019.104578_bib0100","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phrs.2019.104578_bib0105","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/FJC.0b013e318192671d","article-title":"Endocannabinoids and the heart","volume":"53","author":"Hiley","year":"2009","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.phrs.2019.104578_bib0110","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tips.2012.03.002","article-title":"At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunction","volume":"33","author":"Montecucco","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2019.104578_bib0115","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/febs.12260","article-title":"Modulating the endocannabinoid system in human health and disease - Successes and failures","volume":"280","author":"Pacher","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.phrs.2019.104578_bib0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.phrs.2009.04.003","article-title":"Endocannabinoids and cardiac contractile function: pathophysiological implications","volume":"60","author":"B\u00e1tkai","year":"2009","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2019.104578_bib0125","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/3-540-26573-2_20","article-title":"Cardiovascular pharmacology of cannabinoids","author":"Pacher","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.phrs.2019.104578_bib0130","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jcmg.2017.11.019","article-title":"Feasibility evaluation of myocardial cannabinoid type 1 receptor imaging in obesity: a translational approach","volume":"11","author":"Valenta","year":"2018","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.phrs.2019.104578_bib0135","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1476-5381.2012.02042.x","article-title":"Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies","volume":"167","author":"Steffens","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2019.104578_bib0140","series-title":"Is Lipid Signaling Through Cannabinoid 2 Receptors Part of a Protective System?","author":"Pacher","year":"2011"},{"key":"10.1016\/j.phrs.2019.104578_bib0145","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev-biochem-060713-035708","article-title":"Enzyme inhibitor discovery by activity-based protein profiling","volume":"83","author":"Niphakis","year":"2014","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.phrs.2019.104578_bib0150","doi-asserted-by":"crossref","first-page":"14694","DOI":"10.1073\/pnas.96.26.14694","article-title":"Activity-based protein profiling: the serine hydrolases","volume":"96","author":"Liu","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.phrs.2019.104578_bib0155","doi-asserted-by":"crossref","first-page":"12081","DOI":"10.1002\/anie.201306295","article-title":"Development of an activity-based probe and in silico design reveal highly selective inhibitors for diacylglycerol lipase-\u03b1 in brain","volume":"52","author":"Baggelaar","year":"2013","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.phrs.2019.104578_bib0160","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3389\/fphys.2017.00935","article-title":"Alternative splicing of NOX4 in the failing human heart","volume":"8","author":"Varga","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2019.104578_bib0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-07980-5","article-title":"Endocannabinoid tone is higher in healthy lean South Asian than white Caucasian men","volume":"7","author":"Kantae","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2019.104578_bib0170","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/nprot.2017.159","article-title":"Mapping in vivo target interaction profiles of covalent inhibitors using chemical proteomics with label-free quantification","volume":"13","author":"van Rooden","year":"2018","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.phrs.2019.104578_bib0175","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1021\/ac300510t","article-title":"IsoQuant: a software tool for stable isotope labeling by amino acids in cell culture-based mass spectrometry quantitation","volume":"84","author":"Liao","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.phrs.2019.104578_bib0180","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1369\/0022155414530995","article-title":"Validating antibodies to the cannabinoid CB2 receptor: antibody sensitivity is not evidence of antibody specificity","volume":"62","author":"Marchalant","year":"2014","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.phrs.2019.104578_bib0185","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1096\/fj.06-7451com","article-title":"Cannabinoid-2 receptor mediates protection against hepatic ischemia\/reperfusion injury","volume":"21","author":"B\u00e1tkai","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2019.104578_bib0190","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0014-5793(95)01194-J","article-title":"Occurrence and postmortem generation of anandamide and other long-chain N -acylethanolamines in mammalian brain","volume":"375","author":"Schmid","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.phrs.2019.104578_bib0195","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/0006-291X(79)91281-6","article-title":"N-Acylethanolamine accumulation in infarcted myocardium","volume":"90","author":"Epps","year":"1979","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2019.104578_bib0200","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/0005-2760(80)90260-X","article-title":"Accumulation of N-acylethanolamine glycerophospholipids in infarcted myocardium","volume":"618","author":"Epps","year":"1980","journal-title":"Biochim. Biophys. Acta (BBA)\/Lipids Lipid Metab."},{"key":"10.1016\/j.phrs.2019.104578_bib0205","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0005-2760(81)90067-9","article-title":"On the biosynthesis and metabolism of N-acylethanolamine phospholipids in infarcted dog heart","volume":"664","author":"Natarajan","year":"1981","journal-title":"Biochim. Biophys. Acta (BBA)\/Lipids Lipid Metab."},{"key":"10.1016\/j.phrs.2019.104578_bib0210","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0005-2760(82)90352-6","article-title":"N-acylation of ethanolamine phospholipids in canine myocardium","volume":"712","author":"Natarajan","year":"1982","journal-title":"Biochim. Biophys. Acta (BBA)\/Lipids Lipid Metab."},{"key":"10.1016\/j.phrs.2019.104578_bib0215","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1073\/pnas.1522364112","article-title":"Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition","volume":"113","author":"Ogasawara","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.phrs.2019.104578_bib0220","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1021\/acschembio.8b00534","article-title":"Development of a multiplexed activity-based protein profiling assay to evaluate activity of endocannabinoid hydrolase inhibitors","volume":"13","author":"Janssen","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.phrs.2019.104578_bib0225","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1124\/pr.112.006387","article-title":"Chemical probes of endocannabinoid metabolism","volume":"65","author":"Blankman","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phrs.2019.104578_bib0230","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.lfs.2014.11.005","article-title":"Impaired border zone formation and adverse remodeling after reperfused myocardial infarction in cannabinoid CB2 receptor deficient mice","volume":"138","author":"Duerr","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2019.104578_bib0235","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1096\/fj.09-129478","article-title":"The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia\/reperfusion-induced cardiomyopathy","volume":"23","author":"Perier","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2019.104578_bib0240","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.freeradbiomed.2010.11.002","article-title":"Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury","volume":"50","author":"Mukhopadhyay","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2019.104578_bib0245","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/ATVBAHA.112.300275","article-title":"Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice","volume":"33","author":"Lenglet","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2019.104578_bib0250","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jcmg.2012.01.020","article-title":"Coronary vasomotor control in obesity and morbid obesity: contrasting flow responses with endocannabinoids, leptin, and inflammation","volume":"5","author":"Quercioli","year":"2012","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.phrs.2019.104578_bib0255","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/eurheartj\/ehr029","article-title":"Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity","volume":"32","author":"Quercioli","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2019.104578_bib0260","first-page":"499","article-title":"Different expression and function of the endocannabinoid system in human epicardial adipose tissue in relation to heart disease","volume":"29","author":"Cappellano","year":"2013","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.phrs.2019.104578_bib0265","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/CIRCULATIONAHA.108.811992","article-title":"Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages","volume":"119","author":"Sugamura","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2019.104578_bib0270","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ceca.2013.12.005","article-title":"Effects of endogenous cannabinoid anandamide on excitation-contraction coupling in rat ventricular myocytes","volume":"55","author":"Al Kury","year":"2014","journal-title":"Cell Calcium"},{"key":"10.1016\/j.phrs.2019.104578_bib0275","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/00005344-200304000-00020","article-title":"Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle","volume":"41","author":"Bonz","year":"2003","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.phrs.2019.104578_bib0280","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1476-5381.2010.00712.x","article-title":"Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells","volume":"160","author":"Rajesh","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2019.104578_bib0285","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/cvr\/cvp369","article-title":"CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes","volume":"85","author":"Mukhopadhyay","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2019.104578_bib0290","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00125-011-2061-4","article-title":"Cannabinoid 1 receptor activation contributes to vascular inflammation and cell death in a mouse model of diabetic retinopathy and a human retinal cell line","volume":"54","author":"El-Remessy","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2019.104578_bib0295","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2337\/db11-0477","article-title":"Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy","volume":"61","author":"Rajesh","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2019.104578_bib0300","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00395-014-0425-x","article-title":"The endocannabinoid-CB2 receptor axis protects the ischemic heart at the early stage of cardiomyopathy","volume":"109","author":"Duerr","year":"2014","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.phrs.2019.104578_bib0305","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.yjmcc.2009.10.025","article-title":"Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure","volume":"48","author":"Weis","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.phrs.2019.104578_bib0310","series-title":"Life Sci.","first-page":"492","article-title":"Therapeutic potential of monoacylglycerol lipase inhibitors","author":"Mulvihill","year":"2013"},{"key":"10.1016\/j.phrs.2019.104578_bib0315","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pharmthera.2017.02.033","article-title":"Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling","volume":"175","author":"Grabner","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2019.104578_bib0320","first-page":"602","article-title":"2-Arachidonoylglycerol mobilizes myeloid cells and worsens heart function after acute myocardial infarction","volume":"115","author":"Steffens","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2019.104578_bib0325","first-page":"9","article-title":"Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice","volume":"244","author":"Schauer","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2019.104578_bib0330","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1006\/jmcc.1996.0195","article-title":"Purification and characterization of human heart fatty acid ethyl ester synthase\/carboxylesterase","volume":"28","author":"Bora","year":"1996","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.phrs.2019.104578_bib0335","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1006\/jmcc.1998.0812","article-title":"Fatty acid ethyl esters: potentially toxic products of myocardial ethanol metabolism","volume":"30","author":"Beckemeier","year":"1998","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.phrs.2019.104578_bib0340","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11883-008-0017-z","article-title":"Alcohol consumption and heart failure: a systematic review","volume":"10","author":"Djouss\u00e9","year":"2008","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.phrs.2019.104578_bib0345","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCRESAHA.110.226613","article-title":"The critical role of neutral cholesterol ester hydrolase 1 in cholesterol removal from human macrophages","volume":"107","author":"Kumagai","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2019.104578_bib0350","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cmet.2009.08.004","article-title":"Ablation of neutral cholesterol ester hydrolase 1 accelerates atherosclerosis","volume":"10","author":"Sekiya","year":"2009","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2019.104578_bib0355","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N. Engl. J. Med."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819320092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819320092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:07:06Z","timestamp":1760911626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661819320092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":71,"alternative-id":["S1043661819320092"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2019.104578","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activity-based protein profiling of the human failing ischemic heart reveals alterations in hydrolase activities involving the endocannabinoid system","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2019.104578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104578"}}